K2 Principal Fund’s SALIX PHARMACEUTICALS LTD DEL SLXP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q2
Sell
-11,000
Closed -$1.9M 238
2015
Q1
$1.9M Buy
+11,000
New +$1.61M 0.4% 69

Other funds holding SLXP

K2 Principal Fund's SLXP Position: Q2 2015 in Review

K2 Principal Fund sold out of SALIX PHARMACEUTICALS LTD DEL (SLXP) in Q2 2015, closing a stake of 104,080 shares — an estimated $18M sold.

K2 Principal Fund first reported a position in SLXP in Q1 2015 and held it in 1 quarter. The position peaked at $18M in Q1 2015. 1 fund tracked by Wall St. Rank holds SLXP as of Q2 2015.

  • K2 Principal Fund reported no remaining SALIX PHARMACEUTICALS LTD DEL position as of Q2 2015 after selling out during the quarter.
  • K2 Principal Fund sold 104,080 SALIX PHARMACEUTICALS LTD DEL shares in Q2 2015, an estimated $18M.
  • K2 Principal Fund first reported a position in SALIX PHARMACEUTICALS LTD DEL in Q1 2015 and held it in 1 quarter.
  • K2 Principal Fund's SALIX PHARMACEUTICALS LTD DEL position peaked at $18M in Q1 2015.
  • 1 fund tracked by Wall St. Rank held SALIX PHARMACEUTICALS LTD DEL as of Q2 2015.

Based on K2 Principal Fund's 13F filing for Q2 2015, filed 29 Jul 2015.